Development of cyclosporin A mediated immunity in L1210 leukaemia.

about

In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.

P2860

Q41502399-0F769532-7E15-42C8-879C-2887C31F45C9

P2860

Development of cyclosporin A mediated immunity in L1210 leukaemia.

Item

http://www.wikidata.org/entity/Q42371807

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@en

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@nl

type

Item

label

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@en

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@nl

prefLabel

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@en

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@nl

P1476

Development of cyclosporin A mediated immunity in L1210 leukaemia.

@en

P2093

Cho J

http://www.w3.org/2001/XMLSchema#string

Slater LM

http://www.w3.org/2001/XMLSchema#string

Sweet P

http://www.w3.org/2001/XMLSchema#string

Wetzel M

http://www.w3.org/2001/XMLSchema#string

P2860

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.

Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice.

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

Cyclosporine immunosuppression.

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.

Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma.

Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.

P2888

bjc.1991.471

P304

1098-1102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1991.471

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1991-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21392164

http://www.w3.org/2001/XMLSchema#string

P698

1764373

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

1977840

http://www.w3.org/2001/XMLSchema#string

Development of cyclosporin A mediated immunity in L1210 leukaemia.

about

P2860

P2860

Development of cyclosporin A mediated immunity in L1210 leukaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932